Advance Non-small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Advance Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of GFH925 in Combination With Cetuximab in Previously Untreated Advanced NSCLC Harboring KRAS G12C Mutation (NCT05756153) | Genfleet Therapeutics (Shanghai) Inc. | 2023-04-25 |
Track Advance Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.